MANILA, Philippines – The November 2016 Ocular Pharmacology Special Certification exam results, together with the list of passers, performance of schools and related announcements are available at this website as PRC officially released the results online two (2) working days after the last day of board examination.
As announced, 3 out of 11 passed the exams.
The November 2016 special certification exams for Ocular Pharmacology were administered by PRC Board of Optometry headed by its Chairman, Dr. Teresita R. Yambot and its members, Dr. Mary Rose S. Paredes, Dr. Maria Elizabeth B. Valconcha, Dr. Bernardita A. Garcia and Dr. Vivian S. Sarabia on November 22, 2016 at PRC testing center in Manila.
OCULAR PHARMACOLOGY (FOR OPTOMETRIST) LICENSURE EXAMINATION
Held on NOVEMBER 22, 2016
Released on NOVEMBER 24, 2016
Seq. No. N a m e
1 DE OCAMPO, LORRAINE PASCUA
2 EUSTAQUIO, MARILYN JOY LIM
3 MENDOZA, ANGELA BALLESTEROS
REGISTRATION DATE & REQUIREMENTS
Aside from the itemized results posted above, these important registration schedule, requirements and fees shall be secured by a successful examinee.
- The schedule of online appointment for issuance of Professional ID and Certificate of Registration will be on November 29, 2016.
- Registration requirements: duly accomplished Oath Form, latest/current CTC or cedula, 2 pieces of colored passport ID picture with white background and name tag, 2 sets of doc stamps and 1 short envelope with name and profession written.
For Manila board passers, PRC is strictly implementing the online registration system for processing of appointment for registration effective March 30, 2016, details of which are written here.
Ocular Pharmacology is one of the programs with less number of examinees being administered by PRC. On May 2016, 6 out of 19 examinees passed the exams.
To receive up-to-date news about November 2016 Ocular Pharmacology board exam results, we advise our visitors to bookmark this page, visit PRC official website or follow us at our social media pages via Facebook and Twitter.